Irwin Goldstein, MD, Editor-in-Chief of The Journal of Sexual Medicine and Director of the Institute for Sexual Medicine at Boston University School of Medicine, will moderate this controversial debate at the Royal Sonesta Hotel in New Orleans, LA during a champagne breakfast on January 15, 2005. The debate is being held as part of an annual conference given by the Sexual Medicine Society of North America (SMSNA).
According to the World Health Organization, half of men aged 40-70 have sexual dysfunction. Premature ejaculation (PE) is one of the most common forms of dysfunction experienced and it can be caused by either psychological factors or underlying medical conditions.
Arguing in favor of psychological treatment for PE are Michael Perelman, PhD and David Rowland, PhD. Dr. Perelman is Clinical Associate Professor of Psychiatry, Reproductive Medicine, and Urology at Weill Medical College of Cornell University and Dr. Rowland currently serves as editor of the Annual Review of Sex Research.
James Barada, MD, Director of the Albany Center for Sexual Health and Culley Carson, MD, Professor of Surgery and Chief of the Division of Urology at the University of North Carolina at Chapel Hill, will argue in favor of medical therapy.
PE has for a long time been considered a psychological disorder, due to factors such as societal pressures, emotions, and psychological or physical control. However, many question this and cite various physical conditions that may contribute to or be linked to PE. Much success has been reached with treatment by medical therapies, such as PDE-5 inhibitors and anti-depressants. New therapies, including those that raise serotonin, are currently being developed to treat "rapid" ejaculation."
This event is sponsored by Ortho-McNeil Women's Healthcare and Urology and Blackwell Publishing. For more information on how you can attend the debate, please contact the conference coordinator for the Sexual Medicine Society of North America at Jennifer@wjweiser.com. For background information and previous articles on this topic from The Journal of Sexual Medicine, please contact Sharon Agsalda at sagsalda@bos.blackwellpublishing.com.
About The Journal of Sexual Medicine
The Journal of Sexual Medicine is the official journal of the International Society for Sexual Medicine and its five regional affiliate societies. It is the first journal owned and operated by the societies. The aim of the journal is to publish multidisciplinary basic science and clinical research to define and understand the scientific basis of male and female sexual function and dysfunction. The journal provides healthcare professionals in sexual medicine with essential educational content and promotes the exchange of scientific information generated from experimental and clinical research. The Journal of Sexual Medicine includes basic science and clinical research studies in the psychologic and biologic aspects of male and female sexual function and dysfunction, and highlights new observations and research, results with innovative treatments and all other topics relevant to clinical sexual medicine. For more information on The Journal of Sexual Medicine, please visit http://jsm.issir.org.
About Blackwell Publishing
Blackwell Publishing is the world's leading society publisher, partnering with more than 550 academic and professional societies. Blackwell publishes over 750 journals and 600 text and reference books annually, across a wide range of academic, medical, and professional subjects. The company remains independent with over 900 staff members in offices in the US, UK, Australia, China, Denmark, Germany, and Japan. Blackwell's mission as an expert publisher is to create long-term partnerships with our clients that enhance learning, disseminate research, and improve the quality of professional practice. For more information on Blackwell Publishing, please visit www.blackwellpublishing.com or www.blackwell-synergy.com.